Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
disease | 0.100 | None | 0.818 | 11 | 0 | 2013 | 2019 | |||||||||
|
microRNA 195 | 0.496 | 0.769 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2015 | 2019 | |||||||||
|
microRNA 203a | 0.471 | 0.808 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2011 | 2019 | |||||||||
|
hereditary prostate cancer, X-linked | 0.805 | 0.154 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1999 | 2010 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2008 | 2019 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2001 | 2020 | |||||||||
|
Prader Willi/Angelman region RNA 4 | 0.573 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1999 | 2017 | |||||||||
|
microRNA 17 | 0.459 | 0.846 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2015 | 2020 | |||||||||
|
microRNA 183 | 0.494 | 0.885 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2013 | 2020 | |||||||||
|
microRNA 224 | 0.534 | 0.654 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2012 | 2018 | |||||||||
|
microRNA 30d | 0.563 | 0.654 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2012 | 2019 | |||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2011 | 2019 | |||||||||
|
POU class 5 homeobox 1 pseudogene 3 | 0.452 | 0.808 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2009 | 2019 | |||||||||
|
POU class 5 homeobox 1 pseudogene 4 | 0.452 | 0.808 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2009 | 2019 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2001 | 2018 | |||||||||
|
microRNA 193a | 0.541 | 0.731 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2017 | 2019 | |||||||||
|
microRNA 31 | 0.471 | 0.769 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2010 | 2018 | |||||||||
|
microRNA 96 | 0.536 | 0.769 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2013 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 9 | 17 | 2007 | 2014 | |||||||||
|
SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 2013 | 2018 | |||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 8 | 17 | 2007 | 2013 | |||||||||
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 1999 | 2014 | |||||||||
|
microRNA 15a | 0.482 | 0.808 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2010 | 2019 | |||||||||
|
microRNA 29a | 0.459 | 0.808 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2012 | 2020 | |||||||||
|
microRNA 301a | 0.558 | 0.808 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2016 | 2019 |